| 000 -LEADER |
|---|
| fixed length control field |
05900nam a22004935i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150643.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120302s2012 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781461420125 |
|
978-1-4614-2012-5 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC434.2-574 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.89 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
Boston, MA : |
| -- |
Springer US, |
| -- |
2012. |
| 912 ## - |
|---|
| -- |
ZDB-2-SME |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
de Leon, Jose. |
| Relator term |
editor. |
| 245 12 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities |
| Medium |
[electronic resource] / |
| Statement of responsibility, etc |
edited by Jose de Leon. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XXXI, 507p. |
| Other physical details |
online resource. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Introduction -- 2. A Practitioner’s Guide to Prescribing Carbamazepine for Adults with Intellectual Disabilities -- 3. A Practitioner’s Guide to Prescribing Clonazepam for Adults with Intellectual Disabilities -- 4. A Practitioner’s Guide to Prescribing Diazepam for Adults with Intellectual Disabilities -- 5. A Practitioner’s Guide to Prescribing Ethosuximide for Adults with Intellectual Disabilities -- 6. A Practitioner’s Guide to Prescribing Felbamate for Adults with Intellectual Disabilities -- 7. A Practitioner’s Guide to Prescribing Gabapentin for Adults with Intellectual Disabilities -- 8. A Practitioner’s Guide to Prescribing Lacosamide for Adults with Intellectual Disabilities -- 9. A Practitioner’s Guide to Prescribing Lamotrigine For Adults with Intellectual Disabilities -- 10. A Practitioner’s Guide to Prescribing Levetiracetam for Adults with Intellectual Disabilities -- 11. A Practitioner’s Guide to Prescribing Lithium for Adults with Intellectual Disabilities -- 12. A Practitioner’s Guide to Prescribing Lorazepam for Adults with Intellectual Disabilities -- 13. A Practitioner’s Guide to Prescribing Oxacarbazepine for Adults with Intellectual Disabilities -- 14. A Practitioner’s Guide to Prescribing Phenobarbital for Adults with Intellectual Disabilities -- 15. A Practitioner’s Guide to Prescribing Phenytoin for Adults with Intellectual Disabilities -- 16. A Practitioner’s Guide to Prescribing Pregabalin for Adults with Intellectual Disabilities -- 17. A Practitioner’s Guide to Prescribing Primidone for Adults with Intellectual Disabilities -- 18. A Practitioner’s Guide to Prescribing Rufinamide for Adults with Intellectual Disabilities -- 19. A Practitioner’s Guide to Prescribing Tiagabine for Adults with Intellectual Disabilities -- 20. A Practitioner’s Guide to Prescribing Topiramate for Adults with Intellectual Disabilities -- 21. A Practitioner’s Guide to Prescribing Valproate for Adults with Intellectual Disabilities -- 22. A Practitioner’s Guide to Prescribing Zonisamide for Adults with Intellectual Disabilities -- 23. A Practitioner’s Guide to Prescribing Non-oral Antiepileptics for Adults with Intellectual Disabilities -- 24. Conclusion. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Emotional, behavioral, and neuropsychiatric conditions are common in individuals with intellectual disabilities (IDs), most notably epilepsy, aggression, self-injurious behaviors, and bipolar and other mood disorders. Despite the prevalence of such problems, there is a scarcity in the literature of reliable information on medical treatments for those with IDs. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities provides a detailed framework for prescribing for this challenging population. Featuring the most up-to-date information on factors that inform prescribing, the Guide addresses basic issues and controversies (e.g., the rift between evidence-based and personalized medicine) in treating adults with cognitive deficits. Clients' specific needs are emphasized in developing appropriate and effective pharmacological intervention for improved outcomes and quality of life. Drugs discussed in the Guide include carbamazepine, clonazepam, diazepam, ethosuximide, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, lithium, lorazepam, oxcarbazepine, phenobarbital, phenytoin, pregabalin, primidone, rufinamide, tiagabine, topiramate, valproate, and zonisamide. For each of these compounds, the guidelines cover: Indications for use; relative and absolute contraindications. Assessment during treatment; therapeutic drug monitoring; warning signs and symptoms for caretakers. Dosage: administration; initial and maximum recommended dosage; modifications associated with drug-drug interactions, personal characteristics, and (where appropriate) genetic variations. Adverse drug reactions: common, relatively uncommon, and potentially lethal, plus risk of metabolic syndrome. Guidelines for discontinuation. References, tables, and drug utilization reviews. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities is an indispensable decision-making reference for psychiatrists, neuropsychologists, psychopharmacologists, neurologists, internists, and clinical psychologists. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Internal medicine. |
|
|---|
| Topical term or geographic name as entry element |
Neurology. |
|
|---|
| Topical term or geographic name as entry element |
Psychiatry. |
|
|---|
| Topical term or geographic name as entry element |
Psychopharmacology. |
|
|---|
| Topical term or geographic name as entry element |
Psychology, clinical. |
|
|---|
| Topical term or geographic name as entry element |
Medicine & Public Health. |
|
|---|
| Topical term or geographic name as entry element |
Psychiatry. |
|
|---|
| Topical term or geographic name as entry element |
Neuropsychology. |
|
|---|
| Topical term or geographic name as entry element |
Psychopharmacology. |
|
|---|
| Topical term or geographic name as entry element |
Neurology. |
|
|---|
| Topical term or geographic name as entry element |
Internal Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Clinical Psychology. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9781461420118 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-4614-2012-5 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
